Multifunction superpills aren’t nearly as farfetched as they may sound. And reducing such serious risks to heart health as soaring cholesterol, diabetes, and high blood pressure potentially could save many lives and be highly lucrative for drug companies. A combo pill from Pfizer (PFE) of its hypertension drug Norvasc and cholesterol-lowering agent Lipitor "could have huge potential," says Shaojing Tong, analyst at Mehta Partners. "Offering two functions in one pill itself is a huge convenience."
If such pills catch on, they could generate significant revenues for drug companies. In Pfizer’s ease, the goal is to transfer as many qualified patients as possible to the combo pill. Norvasc’s patents expire in 2007, but Pfizer could avoid losing all its revenues from the drug at once if it were part of a superpill. Sena Lund, an analyst at Cathay Financial, sees Pfizer selling $4.2 billion worth of Norvasc-Lipitor by 2007. That would help
A. reducing the various risks to heart health
B. switching the patients to the superpills
C. offering greater convenience to patients
D. increasing the sales of Lipitor
Multifunction superpills aren’t nearly as farfetched as they may sound. And reducing such serious risks to heart health as soaring cholesterol, diabetes, and high blood pressure potentially could save many lives and be highly lucrative for drug companies. A combo pill from Pfizer (PFE) of its hypertension drug Norvasc and cholesterol-lowering agent Lipitor "could have huge potential," says Shaojing Tong, analyst at Mehta Partners. "Offering two functions in one pill itself is a huge convenience."
If such pills catch on, they could generate significant revenues for drug companies. In Pfizer’s ease, the goal is to transfer as many qualified patients as possible to the combo pill. Norvasc’s patents expire in 2007, but Pfizer could avoid losing all its revenues from the drug at once if it were part of a superpill. Sena Lund, an analyst at Cathay Financial, sees Pfizer selling $4.2 billion worth of Norvasc-Lipitor by 2007. That would help
A. Lessening several risks to the heart at the same time.
B. Restoring the lost body functions of the patients.
C. Contributing enormously to the income of drug companies.
D. Helping more patients to reach treatment goals.
Nearly everyone agrees that money doesn’t buy as much as it used to, no matter were you want to spend it. This is certainly true of the paper money that passes so quickly through one’ s hands. Inflation eats away its buying power just as the steady appetite of waves chews at sand cliffs. But what about coins that seem to do very little except make purses and pockets untidy Unlike notes, metal money becomes more valuable the longer it is held, especially if it is put away where it won’t get scratched or worn. Why is this One reason is that coins, being more durable, fall more readily into a category for collections. Naturally, the rarer gold pieces must become more valuable as the price of this metal goes up.
But, curiously, one of the rarest coins in the world is not made of gold, but of the relatively cheaper silver. In 1840, the United States mint struck 19,570 silver dollars. That is what its records show. Today only six of this original number remain
A. silver
B. gold
C. copper
D. paper
我来回答: